Reading this on a mobile device? Try our optimized mobile version here:

April 11, 2012
Sign upForwardArchive
Your resource for current wound care information

  Wound Care Update 
  • Next step for wound care centers may be infusion services
    Wound care centers evolved to serve patients in need of care from multiple specialists, such as podiatrists, vascular surgeons, radiologists, infectious disease experts and hyperbaric oxygen technicians, writes Dr. Thuan Le, chief of staff at Loma Linda University of Murrieta, Calif. But patients who need intravenous therapies often must seek care outside the wound clinic, making infusion services the next logical step in the integrated wound care model, he writes. Today's Wound Clinic magazine (4/2012) LinkedInFacebookTwitterEmail this Story
  • Consider atypical pathogens in nonresponsive infections
    Mycobacterium massiliense is an emerging pathogen that should be suspected in skin and soft tissue infections that do not respond to antibiotics, according to a case study presented at the American Society for Dermatologic Surgery's 2011 meeting. The pathogen is resistant to some chemicals used to sterilize surgical instruments and has been traced to contaminated medications, footbaths, spa beds, tattoo dyes and surgical marking pens, the study authors said. Dermatology Times (4/2012) LinkedInFacebookTwitterEmail this Story
  • FDA issues warning to wound therapy device maker
    The FDA sent a warning letter to device maker Ogenix for failing to adequately test design changes to its Epiflo wound healing device, failing to analyze risks involving the device's strength and durability, and failing to follow recordkeeping requirements. The letter was "routine," said Craig Davis, a managing director with Ogenix, and the company has already responded. (4/4) LinkedInFacebookTwitterEmail this Story
  Research, Technology & Innovation 
  Health Policy & Regulation 
  • Campaign aims to limit unnecessary procedures
    A coalition of medical societies aims to spark discussion and improve decision-making with its Choosing Wisely campaign. The American Board of Internal Medicine Foundation sponsored the effort, which amassed a list of 45 tests and therapies that "should be questioned" because they are often unnecessary or may even cause harm. A variety of tests were addressed in the effort, including imaging for certain cancers. The Washington Post/The Checkup blog (4/4), Chicago Tribune (4/4) LinkedInFacebookTwitterEmail this Story
Learn more about ADVTIS ->Advanced Tissue  |  Meet Our People
Placing An Order  |  Why Use Advanced Tissue
Our Philosophy  |  Facebook

You're never as good as everyone tells you when you win, and you're never as bad as they say when you lose."
--Lou Holtz,
American football coach, sportscaster, author and speaker

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
Quick Links
Why Use Advanced Tissue

Our Philosophy

Meet Our People

Placing An Order

About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes. Advanced Tissue works with clinics throughout the U.S. and its territories to deliver a turnkey wound-supply solution for patients in the home setting as well as long-term care residents. Unit Dose Packaging provides a daily supply of advanced wound dressings packaged in an easy-open package. Our relationship with clinicians in the industry was forged on our innovative delivery model of Unit Dose Packaging and our commitment to not substituting product for financial gain. The ease and simplicity of this system has established Advanced Tissue as an invaluable partner in wound care.

 Recent Advanced Tissue SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information